Despite safety issues, Vioxx still in demand

For every regulatory action, it seems that there must be a backlash. This time, it's a move by consumers to bring back the controversial drug, Vioxx. Patients who once depended on the drug for arthritis relief are still lobbying Merck to get the drug back on the market--despite the documented risk of heart attacks, strokes, even death. Consumer advocates say it might be a case of rose-colored hindsight; patients convinced only Vioxx can help them may simply have exaggerated memories of the drug's effects.

To learn more about this story:
 - read this piece from FiercePharma

Related Articles:
Vioxx defense dealt a blow by new study results. Report
Up to 100,000 Vioxx claims expected. Report
Merck faces long road in Vioxx battle. Report

Post a comment